Dimitrios Bersos - Bioter SA GM CEO

Insider

Dimitrios Bersos is GM CEO of Bioter SA

Age	65
Phone	30 210 72 48 762
Web	https://www.bioter.gr

Bioter SA Management Efficiency

The company has return on total asset (ROA) of (0.0136) % which means that it has lost $0.0136 on every $100 spent on assets. This is way below average. Bioter SA's management efficiency ratios could be used to measure how well Bioter SA manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Bioter SA to Peers

Bioter SA has accumulated 143.2 M in total debt. Bioter SA has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioter SA until it has trouble settling it off, either with new capital or with free cash flow. So, Bioter SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioter SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioter to invest in growth at high rates of return. When we think about Bioter SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Kyriakos Christofas	Ekter SA	53
	Panagiotis Anagnostou	Avax SA	46
	Konstantinos Bouzas	Ekter SA	45
	Athena Eliades	Avax SA	N/A
	Konstantine Mitzalis	Avax SA	N/A
	Giorgios Milonas	Alumil Aluminium Industry	N/A
	Spyridon Mavrikakis	Alumil Aluminium Industry	N/A
	Dimitrios Antonakos	GEK TERNA Holdings	71
	Athanasios Sipsas	Ekter SA	73
	Pinelopi Lazaridou	GEK TERNA Holdings	N/A
	Helen Salata	Intracom Constructions Societe	N/A
	Christos Joannou	Avax SA	51
	George Giannopoulos	Avax SA	N/A
	Konstantine Kouvaras	Avax SA	N/A
	Lamprou Konstantinos	GEK TERNA Holdings	49
	Emmanuel Moustakas	GEK TERNA Holdings	49
	Apostolos Bakogiannis	Ekter SA	50
	Konstantinos Stoumpos	Ekter SA	65
	Georgios Matsaridis	Alumil Aluminium Industry	N/A
	Cleopatra Papastamatiou	Avax SA	N/A
	Anthony Mitzalis	Avax SA	39

Bioter S.A. operates as a construction company in Greece and internationally. The company was founded in 1962 and is based in Athens, Greece. BIOTER S is traded on Athens Stock Exchange in Greece. Bioter SA (BIOT) is traded on Athens Exchange in Greece and employs 1 people.

Management Performance

Return On Asset

-0.0136

Bioter SA Management Team

Elected by the shareholders, the Bioter SA's board of directors comprises two types of representatives: Bioter SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioter. The board's role is to monitor Bioter SA's management team and ensure that shareholders' interests are well served. Bioter SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioter SA's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Dimitrios Bersos, GM CEO
	Milingos Georgios, Chief Accountant
	Ioannis Konstantinopoulos, Ex Chairman

Bioter Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bioter SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Asset	-0.0136
	Operating Margin	(7.66) %
	Current Valuation	166.03 M
	Shares Outstanding	16.73 M
	Shares Owned By Insiders	41.74 %
	Price To Earning	(0.07) X
	Price To Sales	17.36 X
	Revenue	241 K
	Gross Profit	(935 K)
	EBITDA	(1.76 M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Bioter Stock Analysis

When running Bioter SA's price analysis, check to measure Bioter SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioter SA is operating at the current time. Most of Bioter SA's value examination focuses on studying past and present price action to predict the probability of Bioter SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioter SA's price. Additionally, you may evaluate how the addition of Bioter SA to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC